Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

Christopher L. Gaenzle net worth and biography

Christopher Gaenzle Biography and Net Worth

CAO of PRA Health Sciences

Christopher L. Gaenzle serves as Executive Vice President, Chief Administrative Officer, General Counsel of the Company. Mr. Gaenzle joined PRA in April 2019 and serves as Executive Vice President, Chief Administrative Officer and General Counsel of the Company. Mr. Gaenzle has a strong background and expertise in leading large, multi-faceted, and global teams through exceptional growth. As Chief Administrative Officer and General Counsel, he oversees human resources, talent acquisition, quality assurance, compliance, and legal, in addition to data privacy and cybersecurity. Mr. Gaenzle previously served as Chief Administrative Officer, General Counsel and Corporate Secretary at Syneos Health, Inc. (previously INC Research, Inc.) from August 2013 to April 2018, and as General Counsel & Corporate Secretary from April 2012 to April 2018. He has also held leadership roles at Pfizer Inc. and Hunton Andrews Kurth LLP, formery Hunton & Williams LLP.

What is Christopher L. Gaenzle's net worth?: The estimated net worth of Christopher L. Gaenzle is at least $7.46 million as of June 15th, 2021. Mr. Gaenzle owns 45,171 shares of PRA Health Sciences stock worth more than $7,462,701 as of April 27th. This net worth evaluation does not reflect any other assets that Mr. Gaenzle may own. Additionally, Mr. Gaenzle receives an annual salary of $853,970.00 as CAO at PRA Health Sciences. Learn More about Christopher L. Gaenzle's net worth.
How old is Christopher L. Gaenzle?: Mr. Gaenzle is currently 54 years old. There are 3 older executives and no younger executives at PRA Health Sciences. The oldest executive at PRA Health Sciences is Mr. Colin Shannon, Chairman, CEO & Pres, who is 62 years old. Learn More on Christopher L. Gaenzle's age.
What is Christopher L. Gaenzle's salary?: As the CAO of PRA Health Sciences, Inc., Mr. Gaenzle earns $853,970.00 per year. The highest earning executive at PRA Health Sciences is Mr. Colin Shannon, Chairman, CEO & Pres, who commands a salary of $2,030,000.00 per year. Learn More on Christopher L. Gaenzle's salary.
How do I contact Christopher L. Gaenzle?: The corporate mailing address for Mr. Gaenzle and other PRA Health Sciences executives is 4130 PARKLAKE AVENUE SUITE 400, RALEIGH NC, 27612. PRA Health Sciences can also be reached via phone at (919) 786-8200 and via email at [email protected]. Learn More on Christopher L. Gaenzle's contact information.
Has Christopher L. Gaenzle been buying or selling shares of PRA Health Sciences?: Christopher L. Gaenzle has not been actively trading shares of PRA Health Sciences over the course of the past ninety days. Most recently, Christopher L. Gaenzle sold 14,588 shares of the business's stock in a transaction on Tuesday, June 15th. The shares were sold at an average price of $168.28, for a transaction totalling $2,454,868.64. Following the completion of the sale, the chief accounting officer now directly owns 45,171 shares of the company's stock, valued at $7,601,375.88. Learn More on Christopher L. Gaenzle's trading history.
Who are PRA Health Sciences' active insiders?: PRA Health Sciences' insider roster includes Michael Bonello (CFO), Christopher Gaenzle (CAO), and Colin Shannon (CEO). Learn More on PRA Health Sciences' active insiders.

Christopher L. Gaenzle Insider Trading History at PRA Health Sciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/15/2021	Sell	14,588	$168.28	$2,454,868.64	45,171
1/8/2021	Sell	3,136	$130.04	$407,805.44	34,500
8/13/2020	Sell	1,364	$102.88	$140,328.32	37,636

Christopher L. Gaenzle Buying and Selling Activity at PRA Health Sciences

PRA Health Sciences Company Overview

PRA Health Sciences, Inc., a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. It operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services. It also provides strategic solutions, such as embedded, functional services provider, staff augmentation, and custom-built development solutions, as well as commercialization services; and early development services for Phase I and Phase IIa studies, as well as bioanalytical analysis. The Data Solutions segment offers data, analytics, technology, and consulting solutions to the life sciences market. Its services include market intelligence services, such as targeting and compensation, and pharmaceutical audit suite services; consulting and services comprising brand analytics, managed markets, commercial effectiveness, and scientific studies/clinical hubs; and technology-enabled products and services that allow clients to access and analyze Symphony Health and integrated third-party data. PRA Health Sciences, Inc. conducts clinical trials in the areas of pharmaceutical development, including oncology, immunology, central nervous system, inflammation, respiratory, cardiometabolic, and infectious diseases. The company was formerly known as PRA Global Holdings, Inc. and changed its name to PRA Health Sciences, Inc. in July 2014. PRA Health Sciences, Inc. was founded in 1976 and is headquartered in Raleigh, North Carolina.

Today's Range

Now: $165.21

$165.21

50 Day Range

MA: $167.50

$165.21

$174.52

2 Week Range

Now: $165.21

$93.00

$175.95

Volume

57 shs

Average Volume

837,472 shs

Market Capitalization

$10.70 billion

P/E Ratio

50.52

Dividend Yield

N/A

Beta

1.31

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

From Paradigm Press | Ad